Jeffrey W. Albers Blueprint Medicines Corp (BPMC) insider trading activity

BPMC Quotes by TradingView

Jeffrey W. Albers is Director of Blueprint Medicines Corp. Currently has a direct ownership of 0 shares of BPMC, which is worth approximately $0. The most recent transaction as insider was on Aug 19, 2022, when has been sold 1,590 shares (Common Stock) at a price of $70.02 per share, resulting in proceeds of $111,332. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Jeffrey W. Albers Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 19 2022
SELL
Open market or private sale
$111,332 $70.02 p/Share
1,590 Reduced 0.86%
183,243 Common Stock
Aug 19 2022
BUY
Exercise of conversion of derivative security
$23,866 $15.01 p/Share
1,590 Added 0.85%
184,833 Common Stock
Aug 16 2022
SELL
Open market or private sale
$1,374,400 $68.72 p/Share
20,000 Reduced 9.84%
183,243 Common Stock
Aug 16 2022
BUY
Exercise of conversion of derivative security
$168,800 $8.44 p/Share
20,000 Added 8.96%
203,243 Common Stock
Aug 08 2022
SELL
Open market or private sale
$700,700 $70.07 p/Share
10,000 Reduced 5.17%
183,243 Common Stock
Aug 08 2022
BUY
Exercise of conversion of derivative security
$53,400 $5.34 p/Share
10,000 Added 4.92%
193,243 Common Stock
May 16 2022
SELL
Open market or private sale
$1,108,800 $55.44 p/Share
20,000 Reduced 9.84%
183,243 Common Stock
May 16 2022
BUY
Exercise of conversion of derivative security
$168,800 $8.44 p/Share
20,000 Added 8.96%
203,243 Common Stock
Apr 06 2022
SELL
Open market or private sale
$350,550 $70.11 p/Share
5,000 Reduced 2.66%
183,243 Common Stock
Apr 06 2022
BUY
Exercise of conversion of derivative security
$75,050 $15.01 p/Share
5,000 Added 2.59%
188,243 Common Stock
Mar 07 2022
SELL
Open market or private sale
$272,128 $56.19 p/Share
4,843 Reduced 2.57%
183,243 Common Stock
Mar 04 2022
SELL
Open market or private sale
$1,160,000 $58.0 p/Share
20,000 Reduced 9.61%
188,086 Common Stock
Mar 04 2022
BUY
Exercise of conversion of derivative security
$168,800 $8.44 p/Share
20,000 Added 8.77%
208,086 Common Stock
Mar 03 2022
SELL
Open market or private sale
$473,921 $60.28 p/Share
7,862 Reduced 4.01%
188,086 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
7,500 Added 3.69%
195,948 Common Stock
Nov 15 2021
SELL
Open market or private sale
$3,405,300 $113.51 p/Share
30,000 Reduced 13.73%
188,448 Common Stock
Nov 15 2021
BUY
Exercise of conversion of derivative security
$253,200 $8.44 p/Share
30,000 Added 12.07%
218,448 Common Stock
Nov 01 2021
SELL
Open market or private sale
$575,800 $115.16 p/Share
5,000 Reduced 2.58%
188,448 Common Stock
Nov 01 2021
BUY
Exercise of conversion of derivative security
$75,050 $15.01 p/Share
5,000 Added 2.52%
193,448 Common Stock
Aug 26 2021
BUY
Exercise of conversion of derivative security
$29,920 $1.87 p/Share
16,000 Added 7.83%
188,448 Common Stock
Aug 19 2021
SELL
Open market or private sale
$2,315,250 $92.61 p/Share
25,000 Reduced 12.66%
172,448 Common Stock
Aug 19 2021
BUY
Exercise of conversion of derivative security
$211,000 $8.44 p/Share
25,000 Added 11.24%
197,448 Common Stock
May 12 2021
SELL
Open market or private sale
$2,315,250 $92.61 p/Share
25,000 Reduced 12.66%
172,448 Common Stock
May 12 2021
BUY
Exercise of conversion of derivative security
$211,000 $8.44 p/Share
25,000 Added 11.24%
197,448 Common Stock
Mar 04 2021
SELL
Open market or private sale
$1,702,095 $89.65 p/Share
18,986 Reduced 9.92%
172,448 Common Stock

Also insider at

MGTA
Magenta Therapeutics, Inc. Healthcare
Director
KYMR
Kymera Therapeutics, Inc. Healthcare
AGLE
Aeglea BioTherapeutics, Inc. Healthcare
Director
JWA

Jeffrey W. Albers

Director
Cambridge, MA

Track Institutional and Insider Activities on BPMC

Follow Blueprint Medicines Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

News

Receive news related to Blueprint Medicines Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BPMC